We make tissue manufacturing reproducible at every scale, from a single bench to autonomous labs.
Drug developers and clinical teams need human tissue, not animal proxies, at production volume. The field is accelerating toward better preclinical models.
Today the data never connects. Build files, paper notebooks, bioink logs, quality analysis, and assay results are stitched together, so they're difficult to search, communicate, and reproduce.
Five modules cover the workflow, coordinate to predict. Each one replaces a manual step that used to end in a file nobody else could open, and each writes to the same structured record instead.
After the 1962 Kefauver-Harris Amendment raised the evidentiary bar, the industry reorganized around structured, reproducible data. High-throughput screening only became possible because decades of consistent records and standardized compounds existed to screen.
We are on the verge of a preclinical model revolution, and like the last one it will be built on a structured record of every design, process and result.
Capitula spans the whole workflow, from preparation through analysis.
Scaled tissue manufacturing starts with reproducible data, and that starts with your next build. Capitula is built and shipping now.